tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Advertisement

Basilea Pharmaceutica (BSLN) Revenue

Compare
3 Followers

Basilea Pharmaceutica Revenue

Basilea Pharmaceutica had a revenue of 132.25M in the quarter ending Dec 31, 2024, with 73.34%. This bring the company's revenue in the last twelve months to 208.54M, Decreased 39.94%. In the fiscal year ending Dec 31, 2024, Basilea Pharmaceutica had annual revenue of 208.54M with 32.30% growth.
Revenue (ttm)
208.54M
Revenue Growth
32.30%
P/S Ratio
3.18
Revenue/Employee
CHF1,271,604
Employees
164
Market Cap
CHF663.60M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
208.54M50.91M+32.30%
Dec 31, 2023
157.63M9.87M+6.68%
Dec 31, 2022
147.76M-357.00K-0.24%
Dec 31, 2021
148.12M20.49M+16.06%
Dec 31, 2020
127.63M-6.75M-5.02%
Dec 31, 2019
134.38M1.83M+1.38%
Dec 31, 2018
132.56M31.03M+30.57%
Dec 31, 2017
101.52M35.54M+53.86%
Dec 31, 2016
65.98M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis